ANKRD53

Chunjing Jin1, Xu Lu2, Minfeng Yang3,4

  • 1Laboratory Medicine Center, The Affiliated Chuzhou Hospital of Anhui Medical University, The First People's Hospital of Chuzhou, Chuzhou, China.

Discover oncology
|May 27, 2024
PubMed
概括

安基林重复域53 (ANKRD53) 在胃腺癌 (STAD) 中下调. 这项研究确定ANKRD53是STAD预后和免疫治疗反应的潜在生物标志物.